[Management of complications associated with local ablation therapy for hepatocellular carcinoma].
Obi
S
S
Department of Gastroenterology, University of Tokyo.
Shiina
S
S
Imamura
M
M
Teratani
T
T
Satoh
S
S
Koike
Y
Y
Ishikawa
T
T
Akamatsu
M
M
Fujishima
T
T
Tateishi
R
R
Omata
M
M
D006528:Carcinoma, Hepatocellular / Q000628:therapy*; D004564:Electrocoagulation / Q000009:adverse effects*; D004621:Embolization, Therapeutic / Q000009:adverse effects*; D000431:Ethanol / Q000008:administration & dosage / Q000009:adverse effects; D006431:Hemobilia / Q000209:etiology* / Q000628:therapy; D006465:Hemoperitoneum / Q000209:etiology / Q000628:therapy; D006801:Humans; D007238:Infarction / Q000209:etiology / Q000628:therapy; D015552:Injections, Intralesional; D008099:Liver / Q000098:blood supply; D008100:Liver Abscess / Q000209:etiology / Q000628:therapy; D008113:Liver Neoplasms / Q000628:therapy*; D008872:Microwaves / Q000009:adverse effects; D011379:Prognosis
D000431:Ethanol